-
1
-
-
18244373458
-
Mechanisms, pathophysiology, and therapy of arterial stiffness
-
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 932-943
-
-
Zieman, S.J.1
Melenovsky, V.2
Kass, D.A.3
-
3
-
-
0041318888
-
Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function
-
London GM. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-S309
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
London, G.M.1
-
4
-
-
0031780541
-
Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
-
van Guldener C, Janssen MJ, Lambert J et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13: 1782-1786
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 1782-1786
-
-
Van Guldener, C.1
Janssen, M.J.2
Lambert, J.3
-
5
-
-
0030715674
-
Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis
-
Joannides R, Bakkali EH, Le Roy F et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 1997; 12: 2623-2628
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 2623-2628
-
-
Joannides, R.1
Bakkali, E.H.2
Le Roy, F.3
-
6
-
-
0033545950
-
Impact of aortic stiffness on survival in end-stage renal disease
-
Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439
-
(1999)
Circulation
, vol.99
, pp. 2434-2439
-
-
Blacher, J.1
Guerin, A.P.2
Pannier, B.3
-
7
-
-
1642561670
-
Forearm reactive hyperemia and mortality in end-stage renal disease
-
London GM, Pannier B, Agharazii M et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int 2004; 65: 700-704
-
(2004)
Kidney Int
, vol.65
, pp. 700-704
-
-
London, G.M.1
Pannier, B.2
Agharazii, M.3
-
8
-
-
0037174372
-
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy
-
Kjeldsen SE, Dahlof B, Devereux RB et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491-1498
-
(2002)
JAMA
, vol.288
, pp. 1491-1498
-
-
Kjeldsen, S.E.1
Dahlof, B.2
Devereux, R.B.3
-
9
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
10
-
-
1442360727
-
A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness
-
Suzuki H, Nakamoto H, Okada H et al. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003; 19: 59-66
-
(2003)
Adv Perit Dial
, vol.19
, pp. 59-66
-
-
Suzuki, H.1
Nakamoto, H.2
Okada, H.3
-
11
-
-
34347234760
-
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: Results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study
-
Nanayakkara PW, van Guldener C, ter Wee PM et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: Results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 2007; 167: 1262-1270
-
(2007)
Arch Intern Med
, vol.167
, pp. 1262-1270
-
-
Nanayakkara, P.W.1
Van Guldener, C.2
Ter Wee, P.M.3
-
12
-
-
33750103663
-
Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study
-
Takahashi A, Takase H, Toriyama T et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 2006; 21: 2507-2512
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 2507-2512
-
-
Takahashi, A.1
Takase, H.2
Toriyama, T.3
-
13
-
-
49749083154
-
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial
-
Suzuki H, Kanno Y, Sugahara S et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial. Am J Kidney Dis 2008; 52: 501-506
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 501-506
-
-
Suzuki, H.1
Kanno, Y.2
Sugahara, S.3
-
14
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
Wanner C, Krane V, MarzWet al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
-
(2005)
N Engl J Med
, vol.353
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
-
15
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
16
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
-
17
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
-
(2009)
N Engl J Med
, vol.360
, pp. 1395-1407
-
-
Fellstrom, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
-
18
-
-
0346881199
-
Renal replacement therapy in patients with diabetes and end-stage renal disease
-
Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004; 15 (Suppl 1): S25-S29
-
(2004)
J Am Soc Nephrol
, vol.15
, Issue.SUPPL. 1
-
-
Locatelli, F.1
Pozzoni, P.2
Del Vecchio, L.3
-
19
-
-
43749084209
-
Hyperglycemia and the pathobiology of diabetic complications
-
Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 2008; 45: 1-16
-
(2008)
Adv Cardiol
, vol.45
, pp. 1-16
-
-
Aronson, D.1
-
20
-
-
0032588251
-
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin
-
Morsing P, Adler G, Brandt-Eliasson U et al. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999; 33: 1406-1413
-
(1999)
Hypertension
, vol.33
, pp. 1406-1413
-
-
Morsing, P.1
Adler, G.2
Brandt-Eliasson, U.3
-
21
-
-
12244290343
-
Functional antagonism of different angiotensin II type I receptor blockers in human arteries
-
Wagenaar LJ, Voors AA, Buikema H et al. Functional antagonism of different angiotensin II type I receptor blockers in human arteries. Cardiovasc Drugs Ther 2002; 16: 311-316
-
(2002)
Cardiovasc Drugs Ther
, vol.16
, pp. 311-316
-
-
Wagenaar, L.J.1
Voors, A.A.2
Buikema, H.3
-
22
-
-
0035235042
-
NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000
-
Peritoneal Dialysis Adequacy Work Group
-
Peritoneal Dialysis Adequacy Work Group. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000. Am J Kidney Dis 2001; 37: S65-S136
-
(2001)
Am J Kidney Dis
, vol.37
-
-
-
23
-
-
0037116573
-
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
-
Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 257-265
-
-
Corretti, M.C.1
Anderson, T.J.2
Benjamin, E.J.3
-
24
-
-
0042869594
-
Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients
-
Munakata M, Ito N, Nunokawa T et al. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657
-
(2003)
Am J Hypertens
, vol.16
, pp. 653-657
-
-
Munakata, M.1
Ito, N.2
Nunokawa, T.3
-
25
-
-
25444460810
-
Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients
-
Ichihara A, Hayashi M, Kaneshiro Y et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005; 45: 866-874
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 866-874
-
-
Ichihara, A.1
Hayashi, M.2
Kaneshiro, Y.3
-
26
-
-
33751110214
-
Atherosclerosis versus arterial stiffness in advanced renal failure
-
Guerin A, Pannier B, London G. Atherosclerosis versus arterial stiffness in advanced renal failure. Adv Cardiol 2007; 44: 187-198
-
(2007)
Adv Cardiol
, vol.44
, pp. 187-198
-
-
Guerin, A.1
Pannier, B.2
London, G.3
-
27
-
-
73249122122
-
Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity
-
Meng X, Qie L, Wang Y et al. Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity. Clin Invest Med 2009; 32: E238
-
(2009)
Clin Invest Med
, vol.32
-
-
Meng, X.1
Qie, L.2
Wang, Y.3
-
28
-
-
0033039589
-
Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects
-
Nazzaro P, Manzari M, Merlo M et al. Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects. Hypertension 1999; 33: 719-725
-
(1999)
Hypertension
, vol.33
, pp. 719-725
-
-
Nazzaro, P.1
Manzari, M.2
Merlo, M.3
-
29
-
-
39449084717
-
The endothelium as a target in renal diseases
-
Zoccali C. The endothelium as a target in renal diseases. J Nephrol 2007; 20 (Suppl 12): S39-S44
-
(2007)
J Nephrol
, vol.20
, Issue.SUPPL. 12
-
-
Zoccali, C.1
-
30
-
-
58149352649
-
Accelerated atherosclerotic calcification and Monckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease
-
McCullough PA, Agrawal V, Danielewicz E et al. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1585-1598
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1585-1598
-
-
McCullough, P.A.1
Agrawal, V.2
Danielewicz, E.3
-
31
-
-
58149457209
-
Blockage of the reninangiotensin system attenuates mortality but not vascular calcification in uremic rats: Sevelamer carbonate prevents vascular calcification
-
Tokumoto M, Mizobuchi M, Finch JL et al. Blockage of the reninangiotensin system attenuates mortality but not vascular calcification in uremic rats: Sevelamer carbonate prevents vascular calcification. Am J Nephrol 2009; 29: 582-591
-
(2009)
Am J Nephrol
, vol.29
, pp. 582-591
-
-
Tokumoto, M.1
Mizobuchi, M.2
Finch, J.L.3
-
32
-
-
38049033935
-
Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis
-
Kearney PM, Blackwell L, Collins R et al. Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 2008; 371: 117-125
-
(2008)
Lancet
, vol.371
, pp. 117-125
-
-
Kearney, P.M.1
Blackwell, L.2
Collins, R.3
-
33
-
-
48749092662
-
Volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients
-
Cheng LT, Gao YL, Qin C et al. Volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2008; 28: 397-402
-
(2008)
Perit Dial Int
, vol.28
, pp. 397-402
-
-
Cheng, L.T.1
Gao, Y.L.2
Qin, C.3
-
34
-
-
40949129221
-
Residual renal function-one of the factors associated with arterial stiffness in peritoneal dialysis patients Insight from a retrospective study in 146 peritoneal dialysis patients
-
Huang WH, Chen KH, Hsu CW et al. Residual renal function-one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137
-
(2008)
Blood Purif
, vol.26
, pp. 133-137
-
-
Huang, W.H.1
Chen, K.H.2
Hsu, C.W.3
-
35
-
-
0025283892
-
Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension
-
Panza JA, Quyyumi AA, Brush JE Jr. et al. Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27
-
(1990)
N Engl J Med
, vol.323
, pp. 22-27
-
-
Panza, J.A.1
Quyyumi, A.A.2
Brush Jr., J.E.3
-
36
-
-
33947303030
-
A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis
-
Patel TN, Shishehbor MH, Bhatt DL. A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis. Eur Heart J 2007; 28: 664-672
-
(2007)
Eur Heart J.
, vol.28
, pp. 664-672
-
-
Patel, T.N.1
Shishehbor, M.H.2
Bhatt, D.L.3
-
37
-
-
0032229826
-
Epidemiology of cardiovascular disease in chronic renal disease
-
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
-
(1998)
J Am Soc Nephrol
, vol.9
-
-
Foley, R.N.1
Parfrey, P.S.2
Sarnak, M.J.3
|